EICHOR
● Completed
Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease
Condition: Crohn's Disease · Sponsor: Mesoblast, Inc.
About this study
Protocol 610 is enrolling subjects who successfully achieved clinical benefit (reduction in Crohn's Disease Activity Index (CDAI) of at least 100 points) in Protocol 603. Protocol 610 is evaluating the length of initial effect of PROCHYMAL® adult human mesenchymal stem cells and the ability of these cells to successfully re-induce clinical benefit.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (58)
| Advanced Clinical Research Institute | Anaheim, California, United States | — |
| Veteran's Administration Medical Center (does not require vet status) | Long Beach, California, United States | — |
| University of Southern California University Hospital | Los Angeles, California, United States | — |
| University of California, San Francisco | San Francisco, California, United States | — |
| Western States Clinical Research | Wheat Ridge, Colorado, United States | — |
| Gastroenterology Center of Connecticut | Hamden, Connecticut, United States | — |
| Clinical Research of West Florida | Clearwater, Florida, United States | — |
| Borland-Groover Clinic | Jacksonville, Florida, United States | — |
| Venture Research Institute | Miami, Florida, United States | — |
| Shafran Gastroenterology Center | Winter Park, Florida, United States | — |
| Atlanta Gastroenterology Associates | Atlanta, Georgia, United States | — |
| University of Chicago Medical Center | Chicago, Illinois, United States | — |
+ 46 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00543374